NASDAQ:BRNS | Profit Breakdown | Barinthus Biotherapeutics plc.

Complete filed revenue-to-profit bridge showing gross profit, operating income, pre-tax income and net income.

Available history
2020-03-31 to 2026-06-30
Data captured

Historical Profit Breakdown

DateRevenueGross profitOperating incomePre-tax incomeNet income
2026-06-30-$11.02M-$10.62M-$10.58M
2026-03-31-$6.08M-$5.55M-$5.53M
2025-12-31$0.00-$11.57M-$11.16M-$11.09M
2025-09-30$0.00-$15.07M-$14.64M-$14.57M
2025-06-30-$23.32M-$21.15M-$21.12M
2025-03-31-$20.6M-$19.68M-$19.65M
2024-12-31$0.00-$23.39M-$20.59M-$20.54M
2024-09-30$14.97M-$9.38M-$8.13M-$8.11M
2024-06-30$0.00-$18.29M-$16.95M-$16.93M
2024-03-31$0.00-$16.91M-$15.56M-$15.49M
2023-12-31$0.00-$19.99M-$18.11M-$17.29M
2023-09-30$0.00-$16.11M-$14.71M-$14.07M
2023-06-30$334,000.00-$26.34M-$24.96M-$23.8M
2023-03-31$468,000.00-$21.48M-$18.74M-$18.18M
2022-12-31$6.46M-$25.09M-$23.18M-$21.19M
2022-09-30$6.17M$7.24M$7.55M$8.24M
2022-06-30$17.06M$13.24M$14.77M$15.69M
2022-03-31$15.02M$654,000.00$1.71M$2.6M
2021-12-31-$1,000.00-$16.67M-$15.11M
2021-09-30$19,000.00-$5.54M-$4.56M
2021-06-30$35,000.00-$16.85M-$15.93M
2021-03-31$215,000.00-$6.17M-$15.27M
2020-12-31$354,000.00-$9.63M-$10.46M
2020-09-30$3.25M-$1.43M$158,000.00
2020-06-30$511,000.00-$4.34M-$3.59M
2020-03-31$705,000.00-$4.65M-$3.82M

Annual Profit Breakdown

DateRevenueGross profitOperating incomePre-tax incomeNet income
2025-12-31$0.00-$70.56M-$66.63M-$66.43M
2024-12-31$14.97M-$67.97M-$61.23M-$61.07M
2023-12-31$802,000.00-$83.91M-$76.52M-$73.35M
2022-12-31$44.7M-$4.04M$850,000.00$5.34M
2021-12-31$268,000.00-$45.22M-$51.14M-$50.87M
2020-12-31$4.82M-$20.05M-$17.71M